PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer

PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer

Abstract Backgroud Recent studies have indicated that programmed cell death‐ligand 1 (PD‐L1) and cluster of differentiation 47 (CD47) play an essential role in tumor immune evasion and may serve as potential targets for combined immunotherapy. The aim of our study was to evaluate the PD‐L1/CD47 expr...

Full description

Bibliographic Details
Main Authors: Zhenlin Yang, Yue Peng, Wei Guo, Jiachen Xu, Lin Li, He Tian, Renda Li, Lei Liu, Fengwei Tan, Shugeng Gao, Jie He
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Thoracic Cancer
Subjects:
CD47
immunotherapy
non‐small cell lung cancer
PD‐L1
prognosis
Online Access:https://doi.org/10.1111/1759-7714.13989

Internet

https://doi.org/10.1111/1759-7714.13989

Similar Items